New Breakthrough for Cancer Patients
The US Food and Drug Administration last month granted accelerated approval to a new cancer drug for adult and pediatric patients with solid tumors that have a specific genetic mutation detectable through Oncomine Comprehensive, an advanced Next...
Read more